Truist Financial’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-21,866
| Closed | -$657K | – | 2657 |
|
|
2023
Q2 | $657K | Sell |
21,866
-3,302
| -13% | -$99.3K | ﹤0.01% | 1807 |
|
|
2023
Q1 | $912K | Sell |
25,168
-322
| -1% | -$11.7K | ﹤0.01% | 1599 |
|
|
2022
Q4 | $909K | Buy |
25,490
+16,499
| +184% | +$589K | ﹤0.01% | 1595 |
|
|
2022
Q3 | $304K | Sell |
8,991
-8,909
| -50% | -$301K | ﹤0.01% | 2075 |
|
|
2022
Q2 | $517K | Sell |
17,900
-376
| -2% | -$10.9K | ﹤0.01% | 1873 |
|
|
2022
Q1 | $590K | Sell |
18,276
-814
| -4% | -$26.3K | ﹤0.01% | 1903 |
|
|
2021
Q4 | $557K | Buy |
19,090
+771
| +4% | +$22.5K | ﹤0.01% | 1929 |
|
|
2021
Q3 | $489K | Buy |
+18,319
| New | +$489K | ﹤0.01% | 1996 |
|
|
2020
Q3 | – | Sell |
-13,845
| Closed | -$329K | – | 2526 |
|
|
2020
Q2 | $329K | Buy |
13,845
+172
| +1% | +$4.09K | ﹤0.01% | 1872 |
|
|
2020
Q1 | $246K | Buy |
+13,673
| New | +$246K | ﹤0.01% | 1958 |
|